Urinary incontinence symptoms are highly prevalent among women, have a substantial effect on health-related quality of life and are associated with considerable personal and societal expenditure. Two main types are described: stress urinary incontinence, in which urine leaks in association with physical exertion, and urgency urinary incontinence, in which urine leaks in association with a sudden compelling desire to void. Women who experience both symptoms are considered as having mixed urinary incontinence. Research has revealed overlapping potential causes of incontinence, including dysfunction of the detrusor muscle or muscles of the pelvic floor, dysfunction of the neural controls of storage and voiding, and perturbation of the local environment within the bladder. A full diagnostic evaluation of urinary incontinence requires a medical history, physical examination, urinalysis, assessment of quality of life and, when initial treatments fail, invasive urodynamics. Interventions can include non-surgical options (such as lifestyle modifications, pelvic floor muscle training and drugs) and surgical options to support the urethra or increase bladder capacity. Future directions in research may increasingly target primary prevention through understanding of environmental and genetic risks for incontinence.
Subscribe to Journal
Get full journal access for 1 year
only $59.00 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Haylen, B. T. et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol. Urodyn. 29, 4–20 (2009). A useful document on the terminology of urinary incontinence that is important for clinical practice and research.
Shakespeare, K., Barradell, V. & Orme, S. Management of urinary incontinence in frail elderly women. Obstet. Gynaecol. Reprod. Med. 21, 281–287 (2011).
Saarni, S. I. et al. The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual. Life Res. 15, 1403–1414 (2006).
Subak, L. L. et al. High costs of urinary incontinence among women electing surgery to treat stress incontinence. Obstet. Gynecol. 111, 899–907 (2008).
Ganz, M. L. et al. Economic costs of overactive bladder in the United States. Urology 75, 526–532.e18 (2010).
Irwin, D. E. et al. The economic impact of overactive bladder syndrome in six Western countries. BJU Int. 103, 202–209 (2009).
Hannestad, Y. S., Rortveit, G., Sandvik, H. & Hunskaar, S. A community-based epidemiological survey of female urinary incontinence. J. Clin. Epidemiol. 53, 1150–1157 (2000).
Vaughan, C. P. et al. Impact of obesity on urinary storage symptoms: results from the FINNO Study. J. Urol. 189, 1377–1382 (2013).
Greer, W. J., Richter, H. E., Bartolucci, A. A. & Burgio, K. L. Obesity and pelvic floor disorders. Obstet. Gynecol. 112, 341–349 (2008).
Mishra, G. D., Hardy, R., Cardozo, L. & Kuh, D. Body weight through adult life and risk of urinary incontinence in middle-aged women: results from a British prospective cohort. Int. J. Obes. 32, 1415–1422 (2008).
Agarwal, A. et al. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur. Urol. 65, 1211–1217 (2014).
Tikkinen, K. A. O., Leinonen, J. S., Guyatt, G. H., Ebrahim, S. & Järvinen, T. L. N. What is a disease? Perspectives of the public, health professionals and legislators. BMJ Open 2, e001632 (2012).
World Health Organization. International statistical classification of diseases and related health problems. 10th revision. WHOhttp://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf (2010).
Mitteness, L. S. Knowledge and beliefs about urinary incontinence in adulthood and old age. J. Am. Geriatr. Soc. 38, 374–378 (1990).
Norton, P. A., MacDonald, L. D., Sedgwick, P. M. & Stanton, S. L. Distress and delay associated with urinary incontinence, frequency, and urgency in women. BMJ 297, 1187–1189 (1988).
Helfand, B. T., Evans, R. M. & McVary, K. T. A comparison of the frequencies of medical therapies for overactive bladder in men and women: analysis of more than 7.2 million aging patients. Eur. Urol. 57, 586–591 (2010).
Wu, J. M., Matthews, C. A., Conover, M. M., Pate, V. & Jonsson Funk, M. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet. Gynecol. 123, 1201–1206 (2014).
Elstad, E. A., Taubenberger, S. P., Botelho, E. M. & Tennstedt, S. L. Beyond incontinence: the stigma of other urinary symptoms. J. Adv. Nurs. 66, 2460–2470 (2010).
Thom, D. H. et al. Differences in prevalence of urinary incontinence by race/ethnicity. J. Urol. 175, 259–264 (2006).
Klovning, A., Sandvik, H. & Hunskaar, S. Web-based survey attracted age-biased sample with more severe illness than paper-based survey. J. Clin. Epidemiol. 62, 1068–1074 (2009).
Bedretdinova, D., Fritel, X., Panjo, H. & Ringa, V. Prevalence of female urinary incontinence in the general population according to different definitions and study designs. Eur. Urol. 69, 256–264 (2016).
Minassian, V. A., Drutz, H. P. & Al-Badr, A. Urinary incontinence as a worldwide problem. Int. J. Gynecol. Obstet. 82, 327–338 (2003).
Cerruto, M. A., D’Elia, C., Aloisi, A., Fabrello, M. & Artibani, W. Prevalence, incidence and obstetric factors’ impact on female urinary incontinence in Europe: a systematic review. Urol. Int. 90, 1–9 (2013).
Irwin, D. E. et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC Study. Eur. Urol. 50, 1306–1315 (2006).
Minassian, V. A., Stewart, W. F. & Wood, G. C. Urinary incontinence in women. Obstet. Gynecol. 111, 324–331 (2008).
Ebbesen, M. H., Hunskaar, S., Rortveit, G. & Hannestad, Y. S. Prevalence, incidence and remission of urinary incontinence in women: longitudinal data from the Norwegian HUNT study (EPINCONT). BMC Urol. 13, 27 (2013). An important epidemiological study of the natural history of incontinence in women.
Zhang, L. et al. A population-based survey of the prevalence, potential risk factors, and symptom-specific bother of lower urinary tract symptoms in adult Chinese women. Eur. Urol. 68, 97–112 (2015).
Botlero, R., Urquhart, D. M., Davis, S. R. & Bell, R. J. Prevalence and incidence of urinary incontinence in women: review of the literature and investigation of methodological issues. Int. J. Urol. 15, 230–234 (2008).
Thom, D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J. Am. Geriatr. Soc. 46, 473–480 (1998).
Milsom, I. et al. in Incontinence. 5th International Consultation on Incontinence (eds Abrams, P., Cardozo, L., Khoury, S. & Wein, A. ) 15–107 (ICUD-EAU, 2013).
Stewart, W. F. et al. Urinary incontinence incidence: quantitative meta-analysis of factors that explain variation. J. Urol. 191, 996–1002 (2014).
Wu, J. M., Hundley, A. F., Fulton, R. G. & Myers, E. R. Forecasting the prevalence of pelvic floor disorders in U.S. women: 2010 to 2050. Obstet. Gynecol. 114, 1278–1283 (2009).
Goode, P. S. et al. Population based study of incidence and predictors of urinary incontinence in black and white older adults. J. Urol. 179, 1449–1454 (2008).
Mitchell, E. S. & Woods, N. F. Correlates of urinary incontinence during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Climacteric 16, 653–662 (2013).
Fenner, D. E. et al. Establishing the prevalence of incontinence study: racial differences in women's patterns of urinary incontinence. J. Urol. 179, 1455–1460 (2008).
Zhu, L. et al. The epidemiological study of women with urinary incontinence and risk factors for stress urinary incontinence in China. Menopause 16, 831–836 (2009).
Ebbesen, M. H., Hannestad, Y. S., Midthjell, K. & Hunskaar, S. Diabetes and urinary incontinence — prevalence data from Norway. Acta Obstet. Gynecol. Scand. 86, 1256–1262 (2007).
Brown, J. S. et al. Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet. Gynecol. 87, 715–721 (1996).
Gomez-Amaya, S. M., Ruggieri, M. R., Arias Serrato, S. A., Massicotte, V. S. & Barbe, M. F. Gross anatomical study of the nerve supply of genitourinary structures in female mongrel hound dogs. Anat. Histol. Embryol. 44, 118–127 (2014).
Hillary, C. J., Osman, N. & Chapple, C. Considerations in the modern management of stress urinary incontinence resulting from intrinsic sphincter deficiency. World J. Urol. 33, 1251–1256 (2015).
DeLancey, J. O. L. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am. J. Obstet. Gynecol. 170, 1713–1723 (1994). An explanation of stress urinary incontinence pathology and the hammock hypothesis.
Roosen, A. et al. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur. Urol. 56, 810–820 (2009).
Enck, P. et al. Irritable bowel syndrome. Nat. Rev. Dis. Primers 2, 16014 (2016).
Cartwright, R., Afshan, I., Derpapas, A., Vijaya, G. & Khullar, V. Novel biomarkers for overactive bladder. Nat. Rev. Urol. 8, 139–145 (2011).
de Groat, W. C., Griffiths, D. & Yoshimura, N. in Comprehensive Physiology 327–396 (Wiley-Blackwell, 2014).
Li, M., Sun, Y., Simard, J. M. & Chai, T. C. Increased transient receptor potential vanilloid type 1 (TRPV1) signaling in idiopathic overactive bladder urothelial cells. Neurourol. Urodyn. 30, 606–611 (2011).
Reid, G. & Burton, J. P. Urinary incontinence: making sense of the urinary microbiota in clinical urology. Nat. Rev. Urol. 13, 567–568 (2016). An overview of a paradigm shift: the urinary tract is not sterile and bacteria might have important roles in urinary incontinence.
Hilt, E. E. et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J. Clin. Microbiol. 52, 871–876 (2013).
Sorrentino, F. et al. Associations between individual lower urinary tract symptoms and bacteriuria in random urine samples in women. Neurourol. Urodyn. 34, 429–433 (2014).
Walsh, C. A. & Moore, K. H. Overactive bladder in women: does low-count bacteriuria matter? A review. Neurourol. Urodyn. 30, 32–37 (2010).
Khasriya, R. et al. Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms. J. Clin. Microbiol. 51, 2054–2062 (2013).
Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl Acad. Sci. USA 108, 4680–4687 (2010).
Pearce, M. M. et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio 5, e01283-14 (2014).
Brubaker, L. & Wolfe, A. J. Microbiota in 2016: associating infection and incontinence with the female urinary microbiota. Nat. Rev. Urol. 14, 72–74 (2017).
Abrams, P. et al. in Incontinence. 5th International Consultation on Incontinence (eds Abrams, P., Cardozo, L., Khoury, S. & Wein, A. ) 1895–1956 (ICUD-EAU, 2013).
Martin, J. L., Williams, K. S., Sutton, A. J., Abrams, K. R. & Assassa, R. P. Systematic review and meta-analysis of methods of diagnostic assessment for urinary incontinence. Neurourol. Urodyn. 25, 674–683 (2006).
Ruby, C. M. et al. The effect of medication use on urinary incontinence in community-dwelling elderly women. J. Am. Geriatr. Soc. 58, 1715–1720 (2010).
Rait, G. et al. Prevalence of cognitive impairment: results from the MRC trial of assessment and management of older people in the community. Age Ageing 34, 242–248 (2005).
Lucas, M. G. et al. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur. Urol. 62, 1130–1142 (2012).
Wagg, A. et al. Urinary incontinence in frail elderly persons: report from the 5th International Consultation on Incontinence. Neurourol. Urodyn. 34, 398–406 (2014).
Swift, S. E. & Yoon, E. A. Test–retest reliability of the cough stress test in the evaluation of urinary incontinence. Obstet. Gynecol. 94, 99–102 (1999).
Hsu, T. H., Rackley, R. R. & Appell, R. A. The supine stress test: a simple method to detect intrinsic urethral sphincter dysfunction. J. Urol. 162, 460–463 (1999).
Ghoniem, G. et al. Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice. Int. Urogynecol. J. 19, 5–33 (2007). An important paper that describes evaluation and outcome measures for the treatment of stress urinary incontinence.
Orejuela, F. J., Shek, K. L. & Dietz, H. P. The time factor in the assessment of prolapse and levator ballooning. Int. Urogynecol. J. 23, 175–178 (2011).
Bump, R. C. et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am. J. Obstet. Gynecol. 175, 10–17 (1996).
Swift, S. et al. Validation of a simplified technique for using the POPQ pelvic organ prolapse classification system. Int. Urogynecol. J. 17, 615–620 (2006).
Jelovsek, J. E., Maher, C. & Barber, M. D. Pelvic organ prolapse. Lancet 369, 1027–1038 (2007).
Visco, A. G. et al. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int. Urogynecol. J. 19, 607–614 (2008).
Kim, S.-O., Chung, H. S., Hwang, E. C., Oh, K. J. & Kwon, D. Point Aa of the POP-Q system as a predictive value of urethral mobility in women. Int. Urogynecol. J. 22, 687–691 (2010).
Swift, S., Barnes, D., Herron, A. & Goodnight, W. Test–retest reliability of the cotton swab (Q-tip®) test in the evaluation of the incontinent female. Int. Urogynecol. J. 21, 963–967 (2010).
Meyer, I., Szychowski, J. M., Illston, J. D., Parden, A. M. & Richter, H. E. Vaginal swab test compared with the urethral Q-tip test for urethral mobility measurement. Obstet. Gynecol. 127, 348–352 (2016).
Schaer, G., Koechli, O., Schuessler, B. & Haller, U. Perineal ultrasound for evaluating the bladder neck in urinary stress incontinence. Obstet. Gynecol. 85, 220–224 (1995).
Troeger, C., Gugger, M., Holzgreve, W. & Wight, E. Correlation of perineal ultrasound and lateral chain urethrocystography in the anatomical evaluation of the bladder neck. Int. Urogynecol. J. Pelvic Floor Dysfunct. 14, 380–384 (2003).
Richter, H. E. et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstet. Gynecol. 117, 913–921 (2011).
Bo, K. et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int. Urogynecol. J. 28, 191–213 (2016).
Smith, A., Bevan, D., Douglas, H. R. & James, D. Management of urinary incontinence in women: summary of updated NICE guidance. BMJ 347, f5170 (2013). A good summary of the current evidence for treatments of urinary incontinence.
Buchsbaum, G. M., Albushies, D. T. & Guzick, D. S. Utility of urine reagent strip in screening women with incontinence for urinary tract infection. Int. Urogynecol. J. 15, 391–393 (2004).
Hessdoerfer, E., Jundt, K. & Peschers, U. Is a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder? Int. Urogynecol. J. 22, 229–232 (2010).
Holm, A. & Aabenhus, R. Urine sampling techniques in symptomatic primary-care patients: a diagnostic accuracy review. BMC Fam. Pract. 17, 72 (2016).
Cai, T., Koves, B. & Johansen, T. E. B. Asymptomatic bacteriuria, to screen or not to screen — and when to treat? Curr. Opin. Urol. 27, 107–111 (2017).
Nicolle, L. E. Urinary tract infections in the older adult. Clin. Geriatr. Med. 32, 523–538 (2016).
Bettez, M. et al. 2012 update: guidelines for adult urinary incontinence collaborative consensus document for the Canadian Urological Association. Can. Urol. Assoc. J. 6, 354–363 (2012).
Thüroff, J. W. et al. EAU guidelines on urinary incontinence. Eur. Urol. 59, 387–400 (2011).
Saaby, M.-L. & Lose, G. Repeatability of post-void residual urine ≥100 ml in urogynaecologic patients. Int. Urogynecol. J. 23, 207–209 (2012).
Ashton-Miller, J. A. & DeLancey, J. O. Functional anatomy of the female pelvic floor. Ann. NY Acad. Sci. 1101, 266–296 (2007).
Dietz, H. P. Pelvic floor ultrasound in prolapse: what's in it for the surgeon? Int. Urogynecol. J. 22, 1221–1232 (2011).
Dietz, H. P., Nazemian, K., Shek, K. L. & Martin, A. Can urodynamic stress incontinence be diagnosed by ultrasound? Int. Urogynecol. J. 24, 1399–1403 (2013).
Serati, M. et al. Ultrasound measurement of bladder wall thickness in different forms of detrusor overactivity. Int. Urogynecol. J. 21, 1405–1411 (2010).
Bogusiewicz, M. et al. Both the middle and distal sections of the urethra may be regarded as optimal targets for ‘outside-in’ transobturator tape placement. World J. Urol. 32, 1605–1611 (2014).
Herderschee, R., Hay-Smith, E. J. C., Herbison, G. P., Roovers, J. P. & Heineman, M. J. Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst. Rev. 7, CD009252 (2011).
Versi, E. Videourodynamic diagnosis of occult genuine stress incontinence in patients with anterior vaginal wall relaxation. J. Soc. Gynecol. Investig. 5, 327–330 (1998).
Schäfer, W. et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure–flow studies. Neurourol. Urodyn. 21, 261–274 (2002).
Clement, K. D., Lapitan, M. C. M., Omar, M. I. & Glazener, C. M. A. Urodynamic studies for management of urinary incontinence in children and adults. Cochrane Database Syst. Rev. 10, CD003195 (2013).
Digesu, G. A., Khullar, V., Cardozo, L. & Salvatore, S. Overactive bladder symptoms: do we need urodynamics? Neurourol. Urodyn. 22, 105–108 (2003).
Nager, C. W. et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N. Engl. J. Med. 366, 1987–1997 (2012). A seminal RCT that demonstrates that, for women with uncomplicated, demonstrable stress urinary incontinence, preoperative office evaluation alone is not inferior to evaluation with urodynamic testing.
van Leijsen, S. A. L. et al. Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial. Neurourol. Urodyn. 31, 1118–1123 (2012).
Stöhrer, M. et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur. Urol. 56, 81–88 (2009).
Bai, S. W. et al. Relationship between stress urinary incontinence and pelvic organ prolapse. Int. Urogynecol. J. 13, 256–260 (2002).
Burgio, K. L. Update on behavioral and physical therapies for incontinence and overactive bladder: the role of pelvic floor muscle training. Curr. Urol. Rep. 14, 457–464 (2013).
Fonda, D. & Abrams, P. Cure sometimes, help always — a ‘continence paradigm’ for all ages and conditions. Neurourol. Urodyn. 25, 290–292 (2006).
Elkadry, E. A., Kenton, K. S., FitzGerald, M. P., Shott, S. & Brubaker, L. Patient-selected goals: a new perspective on surgical outcome. Am. J. Obstet. Gynecol. 189, 1551–1557 (2003).
Mahajan, S. T., Elkadry, E. A., Kenton, K. S., Shott, S. & Brubaker, L. Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am. J. Obstet. Gynecol. 194, 722–728 (2006).
Vrijens, D. M. J., Spakman, J. I., van Koeveringe, G. A. & Berghmans, B. Patient-reported outcome after treatment of urinary incontinence in a multidisciplinary pelvic care clinic. Int. J. Urol. 22, 1051–1057 (2015).
Myers, D. L. Female mixed urinary incontinence: a clinical review. JAMA 311, 2007–2014 (2014).
Borrie, M. J., Bawden, M., Speechley, M. & Kloseck, M. Interventions led by nurse continence advisers in the management of urinary incontinence: a randomized controlled trial. CMAJ 166, 1267–1273 (2002).
Huang, A. J. Nonsurgical treatments for urinary incontinence in women. JAMA Intern. Med. 173, 1463–1464 (2013).
Hunskaar, S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol. Urodyn. 27, 749–757 (2008).
Subak, L. L., Richter, H. E. & Hunskaar, S. Obesity and urinary incontinence: epidemiology and clinical research update. J. Urol. 182, S2–S7 (2009).
Subak, L. L. et al. Weight loss to treat urinary incontinence in overweight and obese women. N. Engl. J. Med. 360, 481–490 (2009).
Burgio, K. L., Richter, H. E., Clements, R. H., Redden, D. T. & Goode, P. S. Changes in urinary and fecal incontinence symptoms with weight loss surgery in morbidly obese women. Obstet. Gynecol. 110, 1034–1040 (2007).
Dumoulin, C., Hay-Smith, J., Habée-Séguin, Mac, G. & Mercier, J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: a short version Cochrane systematic review with meta-analysis. Neurourol. Urodyn. 34, 300–308 (2014).
Sjöström, M. et al. Internet-based treatment of stress urinary incontinence: 1- and 2-year results of a randomized controlled trial with a focus on pelvic floor muscle training. BJU Int. 116, 955–964 (2015).
Sjöström, M., Umefjord, G., Lindholm, L. & Samuelsson, E. Cost-effectiveness of an Internet-based treatment program for stress urinary incontinence. Neurourol. Urodyn. 34, 244–250 (2013).
Bø, K. Pelvic floor muscle training is effective in treatment of female stress urinary incontinence, but how does it work? Int. Urogynecol. J. Pelvic Floor Dysfunct. 15, 76–84 (2004).
Wyman, J. F., Burgio, K. L. & Newman, D. K. Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. Int. J. Clin. Pract. 63, 1177–1191 (2009).
Miller, J. M., Sampselle, C., Ashton-Miller, J., Hong, G.-R. S. & DeLancey, J. O. L. Clarification and confirmation of the Knack maneuver: the effect of volitional pelvic floor muscle contraction to preempt expected stress incontinence. Int. Urogynecol. J. Pelvic Floor Dysfunct. 19, 773–782 (2008).
Dumoulin, C., Hay-Smith, E. J. C. & Mac Habée-Séguin, G. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst. Rev. 5, CD005654 (2014).
Beyar, N. & Groutz, A. Pelvic floor muscle training for female stress urinary incontinence: five years outcomes. Neurourol. Urodyn. 36, 132–135 (2015).
Glazener, C. M. A. et al. Twelve-year follow-up of conservative management of postnatal urinary and faecal incontinence and prolapse outcomes: randomised controlled trial. BJOG 121, 112–120 (2013).
Richter, H. E. et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence. Obstet. Gynecol. 115, 609–617 (2010).
Morris, A. R. & Moore, K. H. The Contiform incontinence device? Efficacy and patient acceptability. Int. Urogynecol. J. Pelvic Floor Dysfunct. 14, 412–417 (2003).
Weber, M. A. et al. Local oestrogen for pelvic floor disorders: a systematic review. PLoS ONE 10, e0136265 (2015).
Cody, J. D., Richardson, K., Moehrer, B., Hextall, A. & Glazener, C. M. A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst. Rev. 4, CD001405 (2009).
Novara, G. et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur. Urol. 54, 740–764 (2008).
Chapple, C. R. et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur. Urol. 54, 543–562 (2008).
Kubota, Y. et al. Correlation between improvements in overactive bladder symptom score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug. Neurourol. Urodyn. 30, 1309–1314 (2011).
Vouri, S. M., Kebodeaux, C. D., Stranges, P. M. & Teshome, B. F. Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: a systematic review and meta-analysis. Arch. Gerontol. Geriatr. 69, 77–96 (2017).
Oefelein, M. G. Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder. Drug Saf. 34, 733–754 (2011).
Kessler, T. M. et al. Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS ONE 6, e16718 (2011). A useful meta-analysis for choosing a drug for the treatment of overactive bladder based on tolerability, covering the majority of currently licensed preparations.
Kim, T. H. & Lee, K.-S. Persistence and compliance with medication management in the treatment of overactive bladder. Investig. Clin. Urol. 57, 84–93 (2016).
Linnér, L., Schiöler, H., Samuelsson, E., Milsom, I. & Nilsson, F. Low persistence of anticholinergic drug use in Sweden. Eur. J. Clin. Pharmacol. 67, 535–536 (2010).
Yeaw, J., Benner, J. S., Walt, J. G., Sian, S. & Smith, D. B. Comparing adherence and persistence across 6 chronic medication classes. J. Manag. Care Pharm. 15, 728–740 (2009).
Reynolds, W. S. et al. Comparative effectiveness of anticholinergic therapy for overactive bladder in women: a systematic review and meta-analysis. Obstet. Gynecol. 125, 1423–1432 (2015).
Buser, N., Ivic, S., Kessler, T. M., Kessels, A. G. H. & Bachmann, L. M. Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. Eur. Urol. 62, 1040–1060 (2012).
Gray, S. L. et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern. Med. 175, 401–407 (2015).
MacDiarmid, S. et al. Mirabegron as add-on treatment to solifenacin in patients with incontinent overactive bladder and an inadequate response to solifenacin monotherapy. J. Urol. 196, 809–818 (2016).
Drake, M. J. et al. Efficacy and safety of mirabegron add-on therapy to solifenacin in incontinent overactive bladder patients with an inadequate response to initial 4-week solifenacin monotherapy: a randomised double-blind multicentre phase 3B study (BESIDE). Eur. Urol. 70, 136–145 (2016).
Canadian Agency for Drugs and Technologies in Health. in Common Drug Reviewhttps://www.ncbi.nlm.nih.gov/books/NBK349284/ (CADTH, 2015).
Maman, K. et al. Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison. Eur. Urol. 65, 755–765 (2014).
Freemantle, N. et al. Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison. BMJ Open 6, e009122 (2016).
Pindoria, N. et al. Persistence with mirabegron therapy for overactive bladder: a real life experience. Neurourol. Urodyn. 36, 404–408 (2015).
Jost, W. & Marsalek, P. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus. Clin. Auton. Res. 14, 220–227 (2004).
Li, J. et al. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis. Int. Urol. Nephrol. 45, 679–686 (2013).
Hunskaar, S. & Welle-Nilsen, L. K. The market lifecycle of duloxetine for urinary incontinence in Norway. Acta Obstet. Gynecol. Scand. 89, 217–222 (2010).
Ford, A. A., Rogerson, L., Cody, J. D. & Ogah, J. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst. Rev. 7, CD006375 (2015). The most recent Cochrane comparison of mid-urethral slings for stress urinary incontinence.
Latthe, P. M., Singh, P., Foon, R. & Toozs-Hobson, P. Two routes of transobturator tape procedures in stress urinary incontinence: a meta-analysis with direct and indirect comparison of randomized trials. BJU Int. 106, 68–76 (2009).
Novara, G. et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur. Urol. 58, 218–238 (2010).
Rehman, H., Bezerra, C. C., Bruschini, H. & Cody, J. D. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst. Rev. 1, CD001754 (2011).
Lapitan, M. C. M. & Cody, J. D. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst. Rev. 6, CD002912 (2012).
Parden, A. M. et al. Incontinence outcomes in women undergoing primary and repeat midurethral sling procedures. Obstet. Gynecol. 121, 273–278 (2013).
Abdel-Fattah, M., Cao, G. & Mostafa, A. Long-term outcomes for transobturator tension-free vaginal tapes in women with urodynamic mixed urinary incontinence. Neurourol. Urodyn. 36, 902–908 (2016).
Leong, R. K., de Wachter, S. G. G., Joore, M. A. & van Kerrebroeck, P. E. V. Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder. BJU Int. 108, 558–564 (2010).
MacDiarmid, S. A. et al. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J. Urol. 183, 234–240 (2010).
Peters, K. M. et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the Overactive Bladder Innovative Therapy Trial. J. Urol. 182, 1055–1061 (2009).
Amundsen, C. L. et al. OnabotulinumtoxinA versus sacral neuromodulation on refractory urgency urinary incontinence in women. JAMA 316, 1366–1374 (2016).
Visco, A. G. et al. Anticholinergic therapy versus onabotulinumtoxinA for urgency urinary incontinence. N. Engl. J. Med. 367, 1803–1813 (2012). An important RCT that demonstrates the effectiveness of onabotulinumtoxinA for urgency urinary incontinence.
Bartoli, S., Aguzzi, G. & Tarricone, R. Impact on quality of life of urinary incontinence and overactive bladder: a systematic literature review. Urology 75, 491–500 (2010).
Monz, B. et al. Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PURE. Eur. Urol. 51, 1073–1082 (2007).
Haslam, J. Urinary incontinence: why women do not ask for help. Nurs. Times 101, 47–48 (2005).
Temml, C., Haidinger, G., Schmidbauer, J., Schatzl, G. & Madersbacher, S. Urinary incontinence in both sexes: prevalence rates and impact on quality of life and sexual life. Neurourol. Urodyn. 19, 259–271 (2000).
de Vries, H. F., Northington, G. M. & Bogner, H. R. Urinary incontinence (UI) and new psychological distress among community dwelling older adults. Arch. Gerontol. Geriatr. 55, 49–54 (2012).
Salonia, A. et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Eur. Urol. 45, 642–648 (2004).
Yip, S.-K. et al. The impact of urodynamic stress incontinence and detrusor overactivity on marital relationship and sexual function. Am. J. Obstet. Gynecol. 188, 1244–1248 (2003).
Nygaard, I. Idiopathic urgency urinary incontinence. N. Engl. J. Med. 363, 1156–1162 (2010).
Gotoh, M. et al. Impact of urinary incontinence on the psychological burden of family caregivers. Neurourol. Urodyn. 28, 492–496 (2009).
Bekker, M. D. et al. Sexual experiences of men with incontinent partners. J. Sex. Med. 7, 1877–1882 (2010).
Nilsson, M., Lalos, O., Lindkvist, H. & Lalos, A. Impact of female urinary incontinence and urgency on women's and their partners’ sexual life. Neurourol. Urodyn. 30, 1276–1280 (2011).
Kang, Y., Phillips, L. R. & Kim, S.-S. Incontinence quality of life among Korean-American women. Urol. Nurs. 30, 130–136 (2010).
Perez, L. M. & Webster, G. D. The history of urodynamics. Neurourol. Urodyn. 11, 1–21 (1992).
Sheng, W., Zhang, H. & Ruth, K.-H. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis. Neurourol. Urodyn.http://dx.doi.org/10.1002/nau.23210 (2017).
Rachaneni, S. et al. Bladder ultrasonography for diagnosing detrusor overactivity: test accuracy study and economic evaluation. Health Technol. Assess. 20, 1–150 (2016).
Richter, H. E. et al. Genetic contributions to urgency urinary incontinence in women. J. Urol. 193, 2020–2027 (2015).
Cartwright, R. et al. Identification of two novel genomic loci associated with stress and urgency urinary incontinence in a genome wide association study. Int. Urogynecol. J. 26, S53–S54 (2015).
Raz, R. & Stamm, W. E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N. Engl. J. Med. 329, 753–756 (1993).
Brumbaugh, A. R. & Mobley, H. L. T. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev. Vaccines 11, 663–676 (2012).
von Gontard, A., Heron, J. & Joinson, C. Family history of nocturnal enuresis and urinary incontinence: results from a large epidemiological study. J. Urol. 185, 2303–2307 (2011).
Kuh, D., Cardozo, L. & Hardy, R. Urinary incontinence in middle aged women: childhood enuresis and other lifetime risk factors in a British prospective cohort. J. Epidemiol. Community Health 53, 453–458 (1999).
Wilson, D., Dornan, J., Milsom, I. & Freeman, R. UR-CHOICE: can we provide mothers-to-be with information about the risk of future pelvic floor dysfunction? Int. Urogynecol. J. 25, 1449–1452 (2014).
Hallock, J. L. & Handa, V. L. The epidemiology of pelvic floor disorders and childbirth. Obstet. Gynecol. Clin. North Am. 43, 1–13 (2016).
Hunskaar, S., Lose, G., Sykes, D. & Voss, S. The prevalence of urinary incontinence in women in four European countries. BJU Int. 93, 324–330 (2004).
Ferroni, M. C. et al. Role of the brain stem in tibial inhibition of the micturition reflex in cats. Am. J. Physiol. Renal Physiol. 309, F242–F250 (2015).
Fowler, C. J. & Griffiths, D. J. A decade of functional brain imaging applied to bladder control. Neurourol. Urodyn. 29, 49–55 (2009).
Birder, L. & Andersson, K.-E. Urothelial signaling. Physiol. Rev. 93, 653–680 (2013).
Fatton, B., de Tayrac, R. & Costa, P. Stress urinary incontinence and LUTS in women — effects on sexual function. Nat. Rev. Urol. 11, 565–578 (2014).
Lukacz, E. S. et al. Epidemiology of prolapse and incontinence questionnaire: validation of a new epidemiologic survey. Int. Urogynecol. J. 16, 272–284 (2005).
Twiss, C. et al. Validating the Incontinence Symptom Severity Index: a self-assessment instrument for voiding symptom severity in women. J. Urol. 182, 2384–2391 (2009).
Shaw, C. et al. Validity and reliability of a questionnaire to measure the impact of lower urinary tract symptoms on quality of life: the Leicester Impact Scale. Neurourol. Urodyn. 23, 229–236 (2004).
Abraham, L. et al. Development and validation of a quality-of-life measure for men with nocturia. Urology 63, 481–486 (2004).
Coyne, K. S., Thompson, C. L., Lai, J.-S. & Sexton, C. C. An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. Neurourol. Urodyn. 34, 255–263 (2015).
Barber, M. D., Kuchibhatla, M. N., Pieper, C. F. & Bump, R. C. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am. J. Obstet. Gynecol. 185, 1388–1395 (2001).
Barber, M. D., Walters, M. D. & Bump, R. C. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am. J. Obstet. Gynecol. 193, 103–113 (2005).
Brown, J. S. et al. The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann. Intern. Med. 144, 715–723 (2006).
H.W.B. is a Wisconsin Multidisciplinary K12 Urologic Research Career Development Program Scholar (US NIH K12DK100022).
The authors declare no competing interests.
About this article
Cite this article
Aoki, Y., Brown, H., Brubaker, L. et al. Urinary incontinence in women. Nat Rev Dis Primers 3, 17042 (2017). https://doi.org/10.1038/nrdp.2017.42
BMC Women's Health (2021)
Urinary incontinence and the association with depression, stress, and self-esteem in older Korean Women
Scientific Reports (2021)
Treatment of urinary incontinence: a critical appraisal of clinical practice guidelines with the AGREE II instrument
International Urogynecology Journal (2021)
Relationship between urinary incontinence and back or pelvic girdle pain: a systematic review with meta-analysis
International Urogynecology Journal (2021)
Clinical applications of pelvic floor imaging: opinion statement endorsed by the society of abdominal radiology (SAR), American Urological Association (AUA), and American Urogynecologic Society (AUGS)
Abdominal Radiology (2021)